Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Amgen | 4.79% | $3.36B | $181.33B | 22.58% | 77 Outperform | |
| Cisco Systems | 4.66% | $3.27B | $308.35B | 35.72% | 77 Outperform | |
| Merck & Company | 4.46% | $3.13B | $230.63B | -3.83% | 78 Outperform | |
| AbbVie | 4.43% | $3.11B | $410.67B | 40.73% | 62 Neutral | |
| Coca-Cola | 4.17% | $2.92B | $306.10B | 14.26% | 78 Outperform | |
| Chevron | 4.03% | $2.83B | $317.37B | -3.69% | 74 Outperform | |
| PepsiCo | 3.96% | $2.78B | $199.43B | -6.63% | 78 Outperform | |
| Conocophillips | 3.90% | $2.74B | $112.91B | -22.01% | 75 Outperform | |
| Lockheed Martin | 3.88% | $2.73B | $107.78B | -11.33% | 70 Outperform | |
| Bristol-Myers Squibb | 3.85% | $2.70B | $94.97B | -17.59% | 69 Neutral |